Xtant Medical Holdings (XTNT) EBITDA Margin (2010 - 2025)
Xtant Medical Holdings' (XTNT) quarterly EBITDA Margin came in at 7.64% in Q3 2025, up 2116.0% year-on-year from 0.34% in Q3 2024, and down 41.48% on a QoQ basis from 13.06% in Q2 2025.
Xtant Medical Holdings (XTNT) EBITDA Margin (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 16 years of EBITDA Margin data on file, last reported at 7.64% in Q3 2025.
- On a quarterly basis, EBITDA Margin rose 2116.0% year-over-year to 7.64% in Q3 2025; TTM through Sep 2025 was 4.77%, a 1706.0% increase from a year earlier, with the FY2024 full-year figure at 10.3%, up 83.0% from the prior year.
- EBITDA Margin for Q3 2025 stood at 7.64%, down from 13.06% in the prior quarter.
- Over the last five years, EBITDA Margin for XTNT reached as high as 13.06% in Q2 2025 and fell as low as 14.14% in Q1 2022.
- Historically, EBITDA Margin has averaged 7.11% across 5 years, with a median of 9.84% in 2024.
- Across the five-year window, EBITDA Margin slumped 1591 bps in 2021 and jumped 2290 bps in 2025, its largest moves.
- Year by year, EBITDA Margin stood at 13.58% in 2021, then grew by 17 bps to 11.29% in 2022, then fell by 20 bps to 13.54% in 2023, then soared by 56 bps to 5.97% in 2024, then surged by 228 bps to 7.64% in 2025.
- Per Business Quant data, the three most recent EBITDA Margin figures were 7.64% in Q3 2025, 13.06% in Q2 2025, and 3.23% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Xtant Medical Holdings | 5.69 Mn | -11.63 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.64% |
| Jun 30, 2025 | 13.06% |
| Mar 31, 2025 | 3.23% |
| Dec 31, 2024 | -5.97% |
| Sep 30, 2024 | -13.52% |
| Jun 30, 2024 | -9.84% |
| Mar 31, 2024 | -12.45% |
| Dec 31, 2023 | -13.54% |
| Sep 30, 2023 | -13.53% |
| Jun 30, 2023 | -6.88% |
| Mar 31, 2023 | -8.78% |
| Dec 31, 2022 | -11.29% |
| Sep 30, 2022 | -13.14% |
| Jun 30, 2022 | -8.51% |
| Mar 31, 2022 | -14.14% |
| Dec 31, 2021 | -13.58% |
| Sep 30, 2021 | -10.49% |
| Jun 30, 2021 | -3.28% |
| Mar 31, 2021 | -0.04% |
| Dec 31, 2020 | 1.71% |